Katherine Trujillo Useche
Latina Agencia de Noticias de Medicina y Salud Pública
According to an article in the journal Revisited by Medicine and Health Public (MSP), Dr. Gilberto Rivera Gautier, a cardiologist, discusses the various cardiovascular problems that can prevent patients from developing cancer and complications of treatment.
The doctor results in “the cardiovascular treatment of the patient with cancer should begin with an analysis of the patient’s risk, combining the factors of pre-existing cardiovascular risk with the cardiotoxic risk of the drug that is used”.
The doctor explained that he had found the presence of cardiotoxicity induced by chemotherapy, as a reduction in the ventricular expulsion fraction equal to the mayor to 5% in a minor function of 55%, in a patient with a sudden decrease equal the mayor to 10% to a minor function to 55% in an asymptomatic patient.
“Cancer patients are at risk of developing significant cardiovascular problems associated with recurrent treatment,” said Dr. Rivera.
These problems can have the possible cardiovascular effects of cardiovascular agent agents considered cardiovascular and are divided into different groups: the first is the one that primarily affects the cardiac function, the second that affects the vascular function and the dose that affects.
The radiation, treatment for people with cancer, assures the doctor, can cause cardiovascular death at different levels and the cardiotoxicity induced by chemotherapy is classified in group 2 in the classification of the previously mentioned groups.
Cancer patients are at risk of developing significant cardiovascular problems associated with treatment reciprocity.
The doctor recommends that a tempering and maneuver evaluation of a cardiology multidisciplinary team be a great recommendation for the temperament detection and the maneuver appropriate to contribute to a greater quality of life of the affected patients.